Back to catalogue
№ 048 31 filings · 2021-11-21 → 2026-03-25

BRAEMAR PLC

BMS
Industrial Goods and Services Market cap £75m Overall fit 340 /1000

Cheap, well-managed cyclical with strong balance sheet and clear FY30 plan, but essentially zero AI-receiver exposure and only moderate operating leverage make this a partial fit for the strategy despite valuation appeal.

Fair value range 260p–360p Mid case · £100m
Absolute upside +33.4% vs current market cap
Conviction 3/5 confidence in undervalued call
Supports the call
  • Clean disclosure and multiple converging valuation approaches
  • Net cash balance sheet with £40m RCF headroom
  • Quantified FY30 strategic targets with track record of meeting guidance
Limits the call
  • Inherent shipping cycle unpredictability makes forward earnings highly variable
  • Residual legacy obligations (uncertain commission provision, ongoing investigation costs)
Methodology

Forward earnings multiple (9-11x) cross-checked vs discounted FY30 strategic target

In one line · bull case

A cheaply rated, net-cash UK shipbroker with diversified service lines, a credible FY30 growth plan and structural shipping tailwinds, available at ~7x trough P/E.

In one line · biggest risk

Deep shipping cyclicality means another leg down in tanker and dry cargo rates would compress earnings sharply through profit-linked bonus and decremental operating leverage effects.

Drivers
AI beneficiary 20 /100
Pure shipbroking with no AI-driven revenue line; Zuma Labs stake and screen platform are internal tooling, not AI monetisation.
Operating leverage 45 /100
Profit-linked bonuses dampen upside; H1 FY26 showed ~3x decremental leverage but central costs are only ~£6m of a £135m revenue base.
Earnings vs expectations 55 /100
Mostly in line with one notable FY25 downgrade; FY23 strong beat under doubling target; FY26 marginal consensus beat.
Growth momentum 38 /100
Decelerating in FY26 from FY23 peak; FY30 £200m revenue target credible but back-end loaded.
Moat 40 /100
Established global brand and FCA licences but fragmented industry where brokers can take books with them.
Earnings quality 55 /100
Material specific items including £9.1m FY23 goodwill impairment and ongoing investigation/Madrid acquisition costs; APMs needed to see through.
Management quality 55 /100
Current team has nearly doubled FY21 op profit by FY24 and restored capital returns; legacy unlawful dividend and 2013 transaction issues pre-date them.
Cyclicality 78 /100
Tanker, dry cargo and S&P revenues all swing with shipping rates and macro/geopolitics; H1 FY26 tanker rates -29%.
Leverage 15 /100
Net debt £2.9m returning to net cash, £40m RCF with 2.5x EBITDA covenant well-met; close to fortress balance sheet.
Value-trap signals · 5
  • Revenue declining from FY23 peak
  • Dividend cut from 13p (FY24) to 7p (FY25)
  • Historic unlawful dividend rectification via 2023 capital reduction
  • Ongoing 2013-transaction-related provision and residual investigation costs
  • Material US$ revenue / GBP cost FX mismatch creates reported-number noise

BRAEMAR PLC (BMS) — Investment Research Note

Executive summary

Braemar is a global shipbroker offering chartering, sale & purchase, corporate finance, and shipping derivatives advisory across tankers, dry cargo, offshore and specialised vessels. Across FY22–FY26 the new management team simplified the group (disposing of Cory Brothers, Wavespec and AqualisBraemar), grew revenue from £101m to a peak of £153m, and now sits at £135m FY26 revenue with £13.2m underlying operating profit after a weak H1 tanker market 2026-03 FY26 trading update; 2024-05 FY24 results. The single most important point for valuation today is that, on a P/E of ~7x trough earnings with a near-net-cash balance sheet, the shares already discount considerable cyclical weakness — but there is no meaningful AI-receiver thesis here.

Fair value estimate

  • Fair value range: 260p – 360p per share (implied market cap £83m – £116m).
  • Methodology: Blended multiple of forward earnings (primary) and reverse-engineered FY30 path (cross-check).
    • Apply 9–11x to a normalised underlying after-tax profit of c.£9.5–10.5m (FY26 op profit £13.2m × ~75% tax-adjusted, basic EPS ~30p). Range: £85m–£115m.
    • Cross-check vs FY30 target: £200m revenue at 15% underlying op margin = £30m op profit, ~£22m net. At 8x = £180m; discounted back 4 years at 11% = ~£118m, but this is the bull case 2025-05 FY25 results.
  • Latest disclosed market cap: £71.1m
  • Implied upside vs midpoint (310p / £100m): +41%; range +16% to +63%.

Sector context

Confirmed sector: Industrial Goods and Services (ICB Industrials). Braemar's profile is in line with peers on quality, slightly below on growth/scale, and well below on leverage (i.e. stronger balance sheet). Closest listed peers: Clarkson PLC (CKN.L) — the global #1 shipbroker, materially larger and higher multiple; Hunting PLC (HTG.L) — different exposure (oil services); Hellenic Carriers / John Fredriksen vehicles as adjacent shipping-economy plays. Versus Clarkson, Braemar is roughly one-fifth the size and trades on a steep multiple discount that reflects scale, geographic concentration and legacy governance overhangs.

Investment thesis (3 bullets)

  • Cheap, cash-generative cyclical with diversified shipbroking exposure. FY26 net debt of £2.9m, returning to net cash in March 2026; £40m RCF capacity to November 2027; trailing P/E of c.7x trough earnings 2026-03 FY26 trading update; 2025-11 interim results.
  • Strong forward order book and structural shipping tailwinds. $72.5m forward book at FY26 (covering periods to 2039), with an ageing global fleet and constrained yard capacity supporting medium-term rate floors 2026-03 FY26 trading update; 2025-05 FY25 results.
  • Optionality on M&A consolidation and Securities/OTF growth. Active acquisition pipeline in a fragmented shipbroking market; UK OTF launched May 2025, EU OTF and DIFC applications progressing — Risk Advisory revenue +9% in H1 FY26 against group −16% 2025-11 interim results.

Key risks (3 bullets)

  • Deep cyclicality and rate sensitivity. H1 FY26 saw tanker rates −29% and dry cargo −17% year on year, dragging group revenue −16% and underlying op profit −30%. Reverse stress testing showed covenants would break at ~28% revenue decline 2025-11 interim results.
  • Legacy governance / litigation tail. £1.9m provision still recognised for an "uncertain commission obligation" linked to a 2013 transaction, with an account freezing order announced June 2025; ongoing residual investigation costs and Madrid post-contractual obligations 2025-11 interim results, Note 15; 2025-05 FY25 results.
  • FX and sanctions complexity. US-dollar-denominated revenues vs. multi-currency cost base; a weaker dollar in H1 FY26 was a 3pp drag on reported revenue. Sanctions compliance flagged as principal risk with increased net risk in FY25 2025-11 interim results; 2025-05 FY25 results.

Operating leverage

Operating leverage is moderate, not high. Management explicitly states the cost base is "largely fixed or made up of discretionary bonuses which are directly linked to profitability" 2025-11 interim results, Note 2. The bonus-linked share is the key dampener: in good years (FY23 revenue £153m → £20.1m op profit, 13% margin) profits scale up, but in weak years (H1 FY26 revenue −16% → op profit −30%) decremental leverage is significant. Central costs of c.£5–6m and IT/property are fixed; total operating costs run at ~88–90% of revenue. A 10–20% revenue beat on FY26 base would plausibly drop ~35–55% of incremental revenue to profit (i.e. ~£5–15m incremental op profit), roughly +40–100% on current op profit — meaningful but not the 2–3x multiple of profit the user's "long-tail" criterion targets. The FY30 target of 15% operating margin (vs 9.8% in FY26) implies management see further fixed-cost leverage as scale grows 2025-05 FY25 results.

Value-trap signals

  • Revenue trend turned negative in FY26 (£135m vs £141.9m vs £152.9m FY23 peak).
  • Dividend cut from 13p (FY24) to 7p (FY25), partly redirected to £2m buyback — management acknowledged the progressive policy hadn't generated equity value.
  • Historic dividend rectification / capital reduction in 2023 to fix unlawful dividends paid 2016–2023.
  • 2023 internal investigation into a 2013 transaction with continuing residual costs and a £1.9m provision.
  • Reliance on US$ revenues exposes reported figures to non-operational FX swings.
  • Despite all of the above, balance sheet quality and underlying business remain sound; signals are cyclical/legacy, not terminal-decline.

Earnings vs. expectations

  • FY26 (year to Feb 2026): Revenue £135.0m vs consensus £132.0m (range £130.5–134.2m); underlying op profit £13.2m vs consensus £13.2m midpoint — in line / slight beat 2026-03 FY26 trading update.
  • HY26: Revenue £63.9m and underlying op profit £5.1m matched the September 2025 pre-announce (£63.8m / £5.5m); H1 weakness offset by stronger H2 as guided 2025-09 HY26 trading update.
  • FY25: Initially guided "double FY21 op profit by FY25" (target £18m); delivered £16.7m before acquisition-related items — slight miss vs prior consensus £17.5m, with FY25 trading update cutting to "c.£16.5m" in March 2025 2025-03 FY25 trading update; 2025-05 FY25 results.
  • FY24: Underlying op profit £18.1m before acquisition costs vs market consensus £18m — in line 2024-05 FY24 results.
  • FY23: Underlying op profit £20.1m vs initial doubling target (£17.8m) — strong beat 2023-11 FY23 results.
  • Overall pattern: predominantly meets/slightly beats, with one notable miss in FY25; consensus management is competent.

Conviction

Conviction: 3 (moderate). Anchored by: (i) clean, well-disclosed financials with multiple converging valuation approaches; (ii) explicit five-year strategic framework with quantified FY30 targets; (iii) clear track record of meeting/marginally beating guidance under current management. Limited by: (i) the inherent unpredictability of shipping cycles, where any forward earnings estimate is materially exposed to rate swings; (ii) FX translation noise; (iii) some residual legacy obligations whose ultimate outcome remains uncertain.


Driver scoring rationale

  • ai_beneficiary (20): Pure shipbroking — no AI-driven revenue line, no expanding TAM from agentic AI, no productivity moat captured by the firm. Zuma Labs 20% associate stake and braemarscreen.com platform are internal tooling, not monetised AI revenue. Disruptive technology listed as principal risk, suggesting the firm is more likely to be disintermediated than to capture AI value.
  • operating_leverage (45): Moderate. Profit-linked bonuses dampen upside; fixed central and IT costs provide some gearing. H1 FY26 decremental leverage was ~3x revenue change (op profit −30% on revenue −16%) demonstrating real leverage in both directions. Not in the 60+ band reserved for software/platforms.
  • earnings_surprise_trend (55): More beats/in-lines than misses across the disclosed window, with one notable FY25 downgrade. Above-average track record.
  • cyclicality (78): Deeply cyclical shipping markets; tanker rates, dry cargo rates and sale & purchase activity all vary materially with macro/geopolitical conditions. Forward order book provides some smoothing but does not eliminate cyclicality.
  • moat (40): Established global brand, deep client relationships, regulatory licences (UK OTF, FCA-regulated Securities); but a fragmented industry where individual brokers can leave with their books. Closer to "execution-based" than structural moat.
  • leverage (15): Net debt £2.9m at FY26 (returning to net cash), £40m RCF undrawn headroom, EBITDA leverage covenant well within 2.5x limit. Fortress-ish, not net cash, but close.
  • earnings_quality (55): Specific items have been material historically (FY23 £9.1m goodwill impairment, FY25 £4.4m specific charges, ongoing investigation costs). Cash conversion generally good but reporting requires APM unpacking.
  • management_quality (55): Current team (Gundy/Foley/Payne) has executed a credible simplification, restored a progressive capital allocation framework, and grown FY21 op profit of £8.9m to £16.7m in FY25. Offset by historic legacy issues (unlawful dividends, 2013 transaction investigation) that occurred under prior management but cast some shadow.
  • growth_momentum (38): Decelerating — FY26 revenue down YoY, FY25 down YoY from FY24 peak. FY30 ambition of £200m revenue is credible but back-end loaded. Currently in a soft phase of the cycle.
Filings consulted · 43

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-03-25Fy26 Trading Update2026-03-25_9490252_fy26-trading-update.md0.85
  2. 2025-11-05Interim Results2025-11-05_9212783_interim-results.md0.77
  3. 2025-09-25Hy26 Trading Update2025-09-25_9130148_hy26-trading-update.md0.72
  4. 2025-05-29Fy25 Final Results2025-05-29_8901515_fy25-final-results.md0.85
  5. 2025-05-20Investor Presentation AT Mello London2025-05-20_8887603_investor-presentation-at-mello-london.md0.59
  6. 2025-03-24Fy25 Trading Update2025-03-24_8792337_fy25-trading-update.md0.55
  7. 2024-11-06Interim Results2024-11-06_8532021_interim-results.md0.58
  8. 2024-09-19Hy25 Trading Update2024-09-19_8424586_hy25-trading-update.md0.55
  9. 2024-07-03Agm Statement2024-07-03_8291536_agm-statement.md0.26
  10. 2024-06-05Notice OF Agm2024-06-05_8244618_notice-of-agm.md0.20
  11. 2024-05-24Investor Presentation2024-05-24_8219898_investor-presentation.md0.46
  12. 2024-05-23Fy24 Final Results2024-05-23_8215952_fy24-final-results.md0.65
  13. 2024-03-20Fy24 Trading Update2024-03-20_8096443_fy24-trading-update.md0.38
  14. 2023-11-29Interim Results2023-11-29_7908863_interim-results.md0.41
  15. 2023-11-23Notice OF Agm2023-11-23_7900021_notice-of-agm.md0.14
  16. 2023-11-21Restoration OF Listing2023-11-21_7893828_restoration-of-listing.md0.27
  17. 2023-11-21Restoration Braemar Plc2023-11-21_7893820_restoration-braemar-plc.md0.27
  18. 2023-11-20Annual Report IN European Single Electronic Format2023-11-20_7891611_annual-report-in-european-single-electronic-format.md0.43
  19. 2023-11-16Fy23 Final Results2023-11-16_7884389_fy23-final-results.md0.45
  20. 2023-07-17Agm Statement2023-07-17_7637563_agm-statement.md0.18
  21. 2023-07-03Temporary Suspension2023-07-03_7609292_temporary-suspension.md0.45
  22. 2023-03-22Trading Update A Record Year For Braemar2023-03-22_7276379_trading-update-a-record-year-for-braemar.md0.21
  23. 2023-02-14Trading Update And Proposed Capital Reduction2023-02-14_7451728_trading-update-and-proposed-capital-reduction.md0.21
  24. 2022-11-24Investor Presentation2022-11-24_7176925_investor-presentation.md0.17
  25. 2022-11-15Interim Results2022-11-15_7372262_interim-results.md0.23
  26. 2022-11-14Notice OF Half Year Results2022-11-14_7371311_notice-of-half-year-results.md0.23
  27. 2022-09-29Pre Close Trading Update2022-09-29_7168948_pre-close-trading-update.md0.21
  28. 2022-09-14Publication OF Annual Report2022-09-14_7315843_publication-of-annual-report.md0.24
  29. 2022-09-14Change OF Name2022-09-14_7315688_change-of-name.md0.15
  30. 2022-08-31Annual Report Amp Notice OF General Meeting2022-08-31_7162674_annual-report-amp-notice-of-general-meeting.md0.24
  31. 2022-08-30Trading Update2022-08-30_7105300_trading-update.md0.21
  32. 2022-08-30Investor Presentation2022-08-30_7106477_investor-presentation.md0.17
  33. 2022-08-17Update Regarding Publication OF Full Year Results2022-08-17_7128813_update-regarding-publication-of-full-year-results.md0.25
  34. 2022-06-28Notice OF Full Year Results2022-06-28_7116110_notice-of-full-year-results.md0.25
  35. 2022-05-17Notice OF Retail Investor Presentation2022-05-17_6893020_notice-of-retail-investor-presentation.md0.17
  36. 2022-03-01Disposal OF Cory Brothers2022-03-01_6962209_disposal-of-cory-brothers.md0.19
  37. 2022-02-03Trading Update2022-02-03_6707771_trading-update.md0.21
  38. 2021-11-23Presentation Via Investor Meet Company2021-11-23_6837597_presentation-via-investor-meet-company.md0.17
  39. 2021-11-03Interim Results2021-11-03_6657920_interim-results.md0.23
  40. 2021-10-14Trading Update Ahead OF Expectations2021-10-14_6811344_trading-update-ahead-of-expectations.md0.21
  41. 2021-09-22Trading Update Continuing TO Build Momentum2021-09-22_6514145_trading-update-continuing-to-build-momentum.md0.21
  42. 2021-08-26Agm Trading Update2021-08-26_6637112_agm-trading-update.md0.21
  43. 2021-08-03Annual Report And Notice OF Agm2021-08-03_6820804_annual-report-and-notice-of-agm.md0.24

This research note was authored by a large language model after reading 31 regulatory filings published between 2021-11-21 and 2026-03-25. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.